Loomis, Sayles and »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Loomis, Sayles and

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Loomis, Sayles and from 13F filings

Historical chart of Loomis, Sayles and investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Loomis, Sayles and

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 9.0k 397.62
2025-03-31 $160k 594 269.36

More positions owned by Loomis, Sayles and

Nvidia Corp Common (NVDA)
Tesla Common (TSLA)
Alphabet Inc-cl A Common (GOOGL)
Meta Platforms Common (META)
Amazon.com Common (AMZN)
Netflix.com Common (NFLX)
Visa Inc-class A Shrs Common (V)
Oracle Corp Common (ORCL)
Boeing Common (BA)
Microsoft Corp Common (MSFT)
Shopify Inc - Class A Common (SHOP)
Monster Beverage Corporation Common (MNST)
Vertex Pharmaceuticals Common (VRTX)
Autodesk Common (ADSK)
The Walt Disney Common (DIS)

View all positions for Loomis, Sayles and

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Alberta Investment Management Corporation
State Street Corporation
Manufacturers Life Insurance Company
Bnp Paribas Arbitrage, Snc
FMR
MacKay Shields
BlackRock
Lord, Abbett & Co
Warberg Asset Management
Amundi
Bnp Paribas Investment Partners
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1